AndreaBozzo/ceres-open-data-index huggingface dataset:
Pramipexole dihydrochloride

Pramipexole Dihydrochloride is a generic prescription medication available as extended-release oral tablets in strengths of 0.375 mg, 0.75 mg, 1.5 mg, 2.25 mg, 3 mg, 3.75 mg, and 4.5 mg. It acts as a dopamine agonist to help manage symptoms of Parkinson's disease and restless legs syndrome. Manufactured by Ingenus Pharmaceuticals, LLC, under application ANDA213444. This information was generated using AI and is provided for informational and research purposes only.
Louisiana (LA)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Louisiana for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 528818: Flavone, 3,5-dihydroxy-7-methoxy, bis-TMS

Chemical compound data from PubChem database. IUPAC Name: 7-methoxy-2-phenyl-3,5-bis(trimethylsilyloxy)chromen-4-one. Molecular Formula: C22H28O5Si2. Molecular Weight: 428.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400052-T1: [Translated] MEDIUM FOR OPTICAL DATA STORAGE AND METHOD FOR OPTICAL DATA STORAGE

An optical information-recording medium, which comprises a substrate having provided thereon a recording layer capable of recording information by laser beam irradiation, wherein said recording layer contains a naphthol compound represented by the following formula (I): <CHEM> wherein R represents a monovalent substituent other than a hydroxyl group and a SO3<-> group; m represents an integer of from 1 to 4; n represents an integer of from 0 to 7; and p represents an integer of from 0 to 7, provided that m + n + p is 8 or less, when n represents an integer of 2 or more, a plurality of R groups may be the same or different, and when m = p = 2, two hydroxyl groups are not substituted at the 1- and 5-positions or at the 1- and 8-positions at the same time.
Texas (TX)

This report presents estimates for measures of substance use and mental health based on the combined 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided for Texas for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Compound 528646: Trimethylsilyl 2,4-bis[(trimethylsilyl)oxy]butanoate

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2,4-bis(trimethylsilyloxy)butanoate. Molecular Formula: C13H32O4Si3. Molecular Weight: 336.65. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528409: Oxazole, 4-methyl-2-propyl

Chemical compound data from PubChem database. IUPAC Name: 4-methyl-2-propyl-1,3-oxazole. Molecular Formula: C7H11NO. Molecular Weight: 125.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400577-T1: [Translated] ANNATED DIHYDROPYRANS

PCT No. PCT/EP98/03057 Sec. 371 Date Nov. 16, 1999 Sec. 102(e) Date Nov. 16, 1999 PCT Filed May 23, 1998 PCT Pub. No. WO98/54188 PCT Pub. Date Dec. 3, 1998Compounds of formula (I) in which the substituents have the meanings mentioned in the specification, are suitable for the prevention and treatment of gastrointestinal diseases.
SHIP High School Graduation Rate 2010-2022

This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024

High School Graduation Rate - This indicator shows the percentage of students who graduate high school in four years. Completion of high school is one of the strongest predictors of health in later life. People who graduate from high school are more likely to have better health outcomes, regularly visit doctors, and live longer than those without high school diplomas. <a href ="https://health.maryland.gov/pophealth/Documents/SHIP/SHIP%20Lite%20Data%20Details/High%20School%20Graduation%20Rate.pdf" > Link to Data Details </a>
Maryland: 2011-2012 NSDUH

This report presents Maryland\'s estimates for 25 measures of substance use and mental health based on the combined 2011 and 2012 National Surveys on Drug Use and Health (NSDUHs). Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE). Resuts are provided by State and for five age groups: 12 to 17, 18 to 25, 26 or older, 18 or older and all persons 12 or older.
Patent AT-E401568-T1: [Translated] METHOD FOR IDENTIFYING OBJECTS USING AN OPTICAL SPECTROMETER AND A TRANSPORT SYSTEM

A process and an apparatus are useful for identifying articles which are at least partly made from at least one polymer. The process and apparatus use an optical spectrometer and a transport system, whereby the articles to be identified are moved by the transport system past the optical spectrometer, where they are irradiated, response measured and analyzed. An external reference object is also transported, by the transport system, past the optical spectrometer such that it becomes possible to use the measured response for the reference object to identify, with greater accuracy, the articles to be identified.
The Distributed Annotation System

Background
          Currently, most genome annotation is curated by centralized groups with limited resources. Efforts to share annotations transparently among multiple groups have not yet been satisfactory.
        
        
          Results
          Here we introduce a concept called the Distributed Annotation System (DAS). DAS allows sequence annotations to be decentralized among multiple third-party annotators and integrated on an as-needed basis by client-side software. The communication between client and servers in DAS is defined by the DAS XML specification. Annotations are displayed in layers, one per server. Any client or server adhering to the DAS XML specification can participate in the system; we describe a simple prototype client and server example.
        
        
          Conclusions
          The DAS specification is being used experimentally by Ensembl, WormBase, and the Berkeley Drosophila Genome Project. Continued success will depend on the readiness of the research community to adopt DAS and provide annotations. All components are freely available from the project website .
Compound 529826: Carbamodithioic acid, dimethyl, propyl ester

Chemical compound data from PubChem database. IUPAC Name: propyl N,N-dimethylcarbamodithioate. Molecular Formula: C6H13NS2. Molecular Weight: 163.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
v-safe mpox

Users of the v-safe mpox data are required to adhere to the following standards for the analysis and reporting of research data. All research results must be presented and/or published in a manner that protects the confidentiality of participants. v-safe mpox data will not be presented and/or published in any way in which an individual can be identified. 
<br>
<br>Therefore, users will:
<br>
<br>1. Not attempt to link or permit others to link the data with individually identified records in another database.
<br>2. Not attempt to learn the identity of any participant in the data and will not deliberately combine these data with other CDC or non-CDC data for the purpose of matching records to identify individuals. If you should inadvertently discover the identity of any participant, you will ensure the identity of any participant is kept confidential, and will not be used in any publications and/or presentations.
<br>3. Not imply or state, either in written or oral form, that interpretations based on analysis of the data reflect official CDC policies or positions.
<br>4. Understand that sub-national analyses are not appropriate for this national sample and will not be conducted. 
<br>5. Understand that v-safe mpox is a voluntary self-enrollment program requiring smartphone access; therefore, information from v-safe mpox might not be representative or generalizable to the US population.

<br>By clicking on the weblink below to download and use these v-safe data, you signify your agreement to comply with the above-stated terms.
<br>
<br>v-safe mpox is an active surveillance program to monitor the safety of mpox vaccines during the period when the vaccines are authorized for use under Food and Drug Administration (FDA) Emergency Use Authorization (EUA) and after vaccine licensure.
<br>
<br>These data include registrant information (deidentified), health check-in, and vaccination data collected through the mpox response.
Patent AT-E400037-T1: [Translated] DEVICE AND METHOD FOR DETECTING AND TRACKING PERSONS IN AN INVESTIGATION SECTION

The device has a camera for noting the investigation section below the camera unit and for saving the data as a graphic data. A computer detects the characteristics of a person in the investigation section on the basis of a change from graphic and determines a position of a person in the investigation section. The structural form is based on the characteristics on head geometry of a person is based or the geometry of a shoulder of a person. An INDEPEDNENT CLAIM is included for a method.
National Database for Clinical Trials Related to Mental Illness (NDCT)

<p>The National Database for Clinical Trials Related to Mental Illness (NDCT) is an extensible informatics platform for relevant data at all levels of biological and behavioral organization (molecules, genes, neural tissue, behavioral, social and environmental interactions) and for all data types (text, numeric, image, time series, etc.) related to clinical trials funded by the National Institute of Mental Health. Sharing data, associated tools, methodologies and results, rather than just summaries or interpretations, accelerates research progress. Community-wide sharing requires common data definitions and standards, as well as comprehensive and coherent informatics approaches for the sharing of de-identified human subject research data. Built on the National Database for Autism Research (NDAR) informatics platform, NDCT provides a comprehensive data sharing platform for NIMH grantees supporting clinical trials.</p>
Medical Expenditure Panel Survey (MEPS) Insurance Component Data Tools

The Medical Expenditure Panel Survey Insurance Component (MEPS-IC) is an annual survey of private employers and State and local governments. The MEPS-IC produces national and State level estimates of employer-sponsored insurance, including offered plans, costs, employee eligibility, and number of enrollees. With the MEPS-IC Data Tools, users can interactively explore maps, trends, and cross-sectional bar charts for topics related to national and state-level employer-based health insurance for employer characteristics/offerings; employee take-up; premiums; contributions; and cost-sharing. The MEPS-IC is sponsored by the Agency for Healthcare Research and Quality and is fielded by the U.S. Census Bureau.
Head Start Program Information Report (HSPIR)

<p>Information about children enrolled in the Head Start program and information about their families.  Data about the children include: age, type of program attended, health status, and health treatment and/or special services required during enrollment.  Data about the parents include: income, employment status and special services required during child(ren)’s enrollment.  Contact the Head Start Enterprise System (HSES) Help Desk to request access <a href="mailto:help@hsesinfo.org">help@hsesinfo.org</a>.</p>
Guidance to tribes on actions required to complete and submit the (1) Final Report for FYs 2020-2024; (2) the new CFSP for FYs 2025- 2029; and (3) the CFS-101, Parts I, II, and III.

This Program Instruction (PI) provides guidance to Indian Tribes, Indian Tribal Organizations and Indian Tribal Consortia (hereafter “Tribes,” unless otherwise noted) on actions they are required to take to receive their allotments authorized under title IV-B, subparts 1 and 2, and Chafee and ETV programs for Federal Fiscal Year (FY)2 2025 (subject to the availability of appropriations). This PI summarizes requirements for completing and submitting: (1) the Final Report for the 2020-2024 CFSP (2) the new 2025-2029 CFSP, and (3) the CFS-101, Parts I, II, and III.

PI-24-03 (PDF)

For the best access to each attachment, please download and save them to your computer.

FY 2023 Allotment for Title IV-B, Subpart 1 Stephanie Tubbs Jones Child Welfare Services GrantsFY 2023 Allotment for Title IV-B, Subpart 2 Promoting Safe and Stable Families GrantsFY 2023 Allotment for Title IV-B, Subpart 2 Kinship Navigator GrantsFY 2023 Allotment for Chafee Foster Care Program for Successful Transition to Adulthood GrantsFY 2023 Allotment for Education and Training Vouchers GrantsFY 2020 Allotment for Family First Prevention Services Act Transition Grants

CFS-101 Instructions, Part I, II, and III (PDF)

IntroductionPart I: Annual Budget Request for Title IV-B, Subpart 1 & 2 Funds, CAPTA, Chafee, and ETV InstructionsPart II: Annual Estimated Expenditure Summary of Child and Family Services InstructionsPart III: Expenditures for Title IV-B, Subparts 1 and 2, Chafee Foster Care Independence (Chafee) and Education and Training Voucher (ETV) Programs Instructions

CFS-101 Forms, Parts I, II and III Excel Workbook (XLSX)

Assurances and Certifications

Title IV-B, subparts 1 and 2 (PDF)Chafee (PDF)ETV (PDF)

CB Regional Program Managers (PDF)

Tribal Training Plan (Optional) Template (DOCX)

Annual Reporting of Education and Training Vouchers Awarded (PDF)

Certification of Tribal Population Under Age 21 (DOCX)

Tribal CFSP (Optional) Template for FYs 2025-2029 (DOCX)

Tribal Population Data - 2020 Census (PDF)

Metadata-only record linking to the original dataset. Open original dataset below.
2010 State Profile — Tennessee

This state profile includes data from facilities in Tennessee that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in Tennessee. In Tennessee, 202 substance abuse treatment facilities were included in the 2010 N-SSATS, reporting that there were 17,451 clients in substance abuse treatment on March 31, 2010. The survey response rate in Tennessee was 94.7%.
Patent AT-E401789-T1: [Translated] CONTRAPTION

Chemical patent from PubChem database. Patent Number: AT-E401789-T1. Title: Pharmaceutical Salt Forms. Filing Date: 1996-02-02. Inventors: Patel, Amit, Jones, Michael. Abstract: Novel pharmaceutical salt forms are provided, exhibiting improved physicochemical properties including enhanced solubility, stability, and bioavailabi... IPC Classifications: C07D, C07F, A61K. This patent covers 27 claims related to 2 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.
Patent AT-E401179-T1: [Translated] DEVICE FOR INSERTING CONNECTING ELEMENTS INTO THE FRONT AND/OR LONG SIDES OF TECHNICAL WOODEN PRODUCTS

u The device comprises a store (5) for connection elements (4), a transfer arrangement (7) for transferring the connection element from the store to a pressing assembly (8, 13, 14). There may be an arrangement of counter-layers opposite the pressing assembly and one or more magazines (6) for receiving and intermediate layering from the store of connection elements to the transfer arrangement. The arrangement for the magazine may be on the longitudinal side of a transport system (1, 2) for the technical wooden product (3) above or below the transport plane of the wooden product. The store may be made up of a discharge, sorting, aligning and conveying system for pre-fabricated connection element to the transfer arrangement.
Behavioral Risk Factor Surveillance Survey: 2015

The Behavioral Risk Factor Surveillance System (BRFSS) is an annual statewide telephone surveillance system designed by the Centers for Disease Control and Prevention (CDC). BRFSS monitors modifiable risk behaviors and other factors contributing to the leading causes of morbidity and mortality in the population. New York State's BRFSS sample represents the non-institutionalized adult household population, aged 18 years and older. Although the overall number of respondents in the BRFSS is more than sufficiently large for statistical inference purposes, subgroup analyses can lead to estimates that are unreliable. Interpreting and reporting weighted numbers that are based on a small, unweighted number of respondents can mislead the reader into believing that a given finding is much more precise than it actually is. The BRFSS follows a rule of not reporting or interpreting percentages based upon a denominator of fewer than 50 respondents (unweighted sample). Both a csv and sas data files are available. For more information, check out http://www.health.ny.gov/statistics/brfss/.
Compound 527984: Decanoic acid, 2-chloro-1-(chloromethyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 1,3-dichloropropan-2-yl decanoate. Molecular Formula: C13H24Cl2O2. Molecular Weight: 283.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Inconsequential Role for Chemerin-Like Receptor 1 in a Manifestation of Ozone-Induced Lung Pathophysiology in Male Mice

Chemerin, a non-chemokine chemoattractant, and resolvin E1 (RvE1), a specialized pro-resolving lipid mediator, are endogenous ligands for chemerin-like receptor 1 (CMKLR1), a Gi/o protein-coupled receptor expressed by leukocytes and non-leukocytes.  In mice, exogenous administration of chemerin or RvE1 diminishes the severity of lung inflammation and airway hyperresponsiveness (AHR) induced by antigen sensitization and challenge, which mimics phenotypic features of atopic asthma in humans.  However, the contribution of chemerin or RvE1 to features of non-atopic asthma is unknown.  Therefore, to indirectly assess if chemerin or RvE1 facilitates development of a non-atopic asthma phenotype, which includes AHR to acetyl-β-methylcholine chloride, lung hyperpermeability, airway epithelial cell desquamation, and lung inflammation, we quantified features of these sequelae in wild-type mice and mice failing to express CMKLR1 (CMKLR1-deficient mice) following cessation of acute inhalation exposure to either filtered room air or ozone, a criteria pollutant and non-atopic asthma stimulus.
Compound 525533: (3-Methoxy-4-hexyloxy-phenyl)-propionic acid, methyl ester

Chemical compound data from PubChem database. IUPAC Name: methyl 3-(4-hexoxy-3-methoxyphenyl)propanoate. Molecular Formula: C17H26O4. Molecular Weight: 294.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NCHS - Childhood Mortality Rates

This dataset of U.S. mortality trends since 1900 highlights childhood mortality rates by age group for age at death.

Age-adjusted death rates (deaths per 100,000) after 1998 are calculated based on the 2000 U.S. standard population. Populations used for computing death rates for 2011–2017 are postcensal estimates based on the 2010 census, estimated as of July 1, 2010. Rates for census years are based on populations enumerated in the corresponding censuses. Rates for noncensus years between 2000 and 2010 are revised using updated intercensal population estimates and may differ from rates previously published. Data on age-adjusted death rates prior to 1999 are taken from historical data (see References below).

Age groups for childhood death rates are based on age at death.

SOURCES

CDC/NCHS, National Vital Statistics System, historical data, 1900-1998 (see https://www.cdc.gov/nchs/nvss/mortality_historical_data.htm); CDC/NCHS, National Vital Statistics System, mortality data (see http://www.cdc.gov/nchs/deaths.htm); and CDC WONDER (see http://wonder.cdc.gov).

REFERENCES

1. National Center for Health Statistics, Data Warehouse. Comparability of cause-of-death between ICD revisions. 2008. Available from: http://www.cdc.gov/nchs/nvss/mortality/comparability_icd.htm.

2. National Center for Health Statistics. Vital statistics data available. Mortality multiple cause files. Hyattsville, MD: National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data_access/vitalstatsonline.htm.

3. Kochanek KD, Murphy SL, Xu JQ, Arias E. Deaths: Final data for 2017. National Vital Statistics Reports; vol 68 no 9. Hyattsville, MD: National Center for Health Statistics. 2019. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_09-508.pdf.

4. Arias E, Xu JQ. United States life tables, 2017. National Vital Statistics Reports; vol 68 no 7. Hyattsville, MD: National Center for Health Statistics. 2019. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr68/nvsr68_07-508.pdf.

5. National Center for Health Statistics. Historical Data, 1900-1998. 2009. Available from: https://www.cdc.gov/nchs/nvss/mortality_historical_data.htm.
Compound 527147: Butamifos oxon

Chemical compound data from PubChem database. IUPAC Name: N-[ethoxy-(5-methyl-2-nitrophenoxy)phosphoryl]butan-2-amine. Molecular Formula: C13H21N2O5P. Molecular Weight: 316.29. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400843-T1: [Translated] INTEGRATED CIRCUIT WITH A TRUE RANDOM NUMBER GENERATOR

An integrated circuit (1..1''',1a..1c) with a true random number generator (2..2'''), which comprises at least one instable physical uncloneable function (3..3''',3a,3a') for generating true random numbers (8). Hence each device of a group of devices can be provided with a unique true random generator so that each device of the group is provided with different true random numbers even when said devices are applied to identical environmental conditions. Such a random number generator may be part of a smart card as well as of a module for near field communication for example.
Patent AT-E400610-T1: [Translated] HYDROPHOBIC ADDITIVE

Hydrophobicizing additives are water-redispersible powders or aqueous dispersions containing: a) water-insoluble, film-forming base polymer(s) based on homopolymers or copolymers of one or more vinyl esters of optionally branched C1-15 alkylcarboxylic, (meth)acrylic esters of C1-15 alcohols, vinylaromatics, olefins, dienes and vinyl halides, b) one or more hydrophobic organosilicon compounds, fatty acids, or derivatives thereof, or hydrocarbon waxes, and c) one or more protective colloids, wherein the proportion of the component b) based on the total weight of the component a) is more than 30% by weight.